Hybrid closed loop technologies for type 1 diabetes patients
The phased implementation of a programme to roll-out Hybrid Closed Loop technology over the next five years to tens of thousands of patients living with type 1 diabetes has launched. Integrated Care Systems (ICSs) will work with, and support, patients who are eligible, including adults with a HbA1c of 7.5% and above, people aged under 18 and women who are pregnant or planning pregnancy.